An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Clinical trial NCT00153010 · COMPLETED

Trial details

NCT number: NCT00153010
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2003-02-01
Primary completion: 2005-03-01
Enrollment: 430

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.